Wikisage, the free encyclopedia of the second generation, is digital heritage

Bezafibrate: Difference between revisions

From Wikisage
Jump to navigation Jump to search
(Created page with "Bezafibrate was originally developed as a drug for treatment of hyperlipidemia and used for the prevention of cardiovascular diseases <ref>[http://www.ncbi.nlm.nih.gov/pmc/art...")
 
No edit summary
Line 1: Line 1:
Bezafibrate was originally developed as a drug for treatment of hyperlipidemia and used for the prevention of cardiovascular diseases
Bezafibrate was originally developed as a drug for treatment of hyperlipidemia and used for the prevention of cardiovascular diseases
<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599574/ Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis]</ref>
<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599574/ Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis]</ref>
 
<ref>[http://www.impactjournals.com/oncotarget/misc/linkedout.php?pii=4528 Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysis]</ref>
<references/>
<references/>

Revision as of 23:48, 4 November 2015

Bezafibrate was originally developed as a drug for treatment of hyperlipidemia and used for the prevention of cardiovascular diseases [1] [2]